ID

37089

Description

Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02264301

Link

https://clinicaltrials.gov/show/NCT02264301

Keywords

Versions (1)
  1. 7/2/19 7/2/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 2, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Rheumatoid Arthritis NCT02264301

English

Eligibility Rheumatoid Arthritis NCT02264301

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
with active ra
Description

Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1]
C0003873
without taking any other medication for the treatment of active ra in at least 4 last weeks
Description

Pharmaceutical Preparations Other Absent | Therapeutic procedure Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0003873
aged from 18 to 75 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
without conflict to the written, informed consent signed prior to the enrollment.
Description

Informed Consent | Conflict Absent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0009671
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
being included in other clinical trial within the last 4 weeks
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
with abnormal liver or kidney function (more than 1 time above the high normal)
Description

Increased liver function | Increased renal function

Data type

boolean

Alias
UMLS CUI [1]
C0232743
UMLS CUI [2]
C0232806
with serious cardiovascular disease
Description

Cardiovascular Disease Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205404
with hematologic disease
Description

Hematological Disease

Data type

boolean

Alias
UMLS CUI [1]
C0018939
being in pregnancy, lactation period or under a pregnancy plan
Description

Pregnancy | Breast Feeding | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
with severe gastrointestinal disease
Description

Gastrointestinal Disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0205082
with contraindication or being allergic to the test drugs
Description

Medical contraindication Investigational New Drugs | Hypersensitivity Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, immunosuppressants, anti-ulcer drugs
Description

Pharmacotherapy Affecting Research results | Anti-Inflammatory Agents, Non-Steroidal | Steroidal anti-inflammatory drugs | Immunosuppressive Agents | Anti-Ulcer Agent

Data type

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0683954
UMLS CUI [2]
C0003211
UMLS CUI [3]
C0003212
UMLS CUI [4]
C0021081
UMLS CUI [5]
C0003216
being not compatible for the trial medication, or other circumstances at the discretion of investigators
Description

Incompatibility Investigational New Drugs | Life circumstances Other

Data type

boolean

Alias
UMLS CUI [1,1]
C0679426
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0680082
UMLS CUI [2,2]
C0205394
without legal capacity or only with limited legal capacity.
Description

Legal capacity Absent | Legal capacity Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C0683673
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0683673
UMLS CUI [2,2]
C0439801
Back to the top of the page

Similar models

Eligibility Rheumatoid Arthritis NCT02264301

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis
Item
with active ra
boolean
C0003873 (UMLS CUI [1])
Pharmaceutical Preparations Other Absent | Therapeutic procedure Rheumatoid Arthritis
Item
without taking any other medication for the treatment of active ra in at least 4 last weeks
boolean
C0013227 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Age
Item
aged from 18 to 75 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Conflict Absent
Item
without conflict to the written, informed consent signed prior to the enrollment.
boolean
C0021430 (UMLS CUI [1])
C0009671 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
being included in other clinical trial within the last 4 weeks
boolean
C2348568 (UMLS CUI [1])
Increased liver function | Increased renal function
Item
with abnormal liver or kidney function (more than 1 time above the high normal)
boolean
C0232743 (UMLS CUI [1])
C0232806 (UMLS CUI [2])
Cardiovascular Disease Serious
Item
with serious cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Hematological Disease
Item
with hematologic disease
boolean
C0018939 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
being in pregnancy, lactation period or under a pregnancy plan
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Gastrointestinal Disease Severe
Item
with severe gastrointestinal disease
boolean
C0017178 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Medical contraindication Investigational New Drugs | Hypersensitivity Investigational New Drugs
Item
with contraindication or being allergic to the test drugs
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Pharmacotherapy Affecting Research results | Anti-Inflammatory Agents, Non-Steroidal | Steroidal anti-inflammatory drugs | Immunosuppressive Agents | Anti-Ulcer Agent
Item
being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, immunosuppressants, anti-ulcer drugs
boolean
C0013216 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2])
C0003212 (UMLS CUI [3])
C0021081 (UMLS CUI [4])
C0003216 (UMLS CUI [5])
Incompatibility Investigational New Drugs | Life circumstances Other
Item
being not compatible for the trial medication, or other circumstances at the discretion of investigators
boolean
C0679426 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0680082 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Legal capacity Absent | Legal capacity Limited
Item
without legal capacity or only with limited legal capacity.
boolean
C0683673 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0683673 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial